Geode Capital Management
GTBP icon

Geode Capital Management’s GT Biopharma GTBP Stock Holding History

Geode Capital Management’s Portfolio GTBP Stock Details GTBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$120K Buy
294,459
+275,201
+1,429% +$150K ﹤0.01% 4086
2025
Q4 		$15.1K Sell
19,258
-4,708
-20% -$3.34K ﹤0.01% 4409
2025
Q3 		$14.3K Buy
23,966
+129
+0.5% +$193 ﹤0.01% 4438
2025
Q2 		$85.4K Buy
23,837
+751
+3% +$1.94K ﹤0.01% 4104
2025
Q1 		$51.7K Buy
23,086
+8,187
+55% +$19.3K ﹤0.01% 4193
2024
Q4 		$45.5K Sell
14,899
-142
-0.9% -$384 ﹤0.01% 4257
2024
Q3 		$34.5K Buy
15,041
+3,857
+34% +$9.21K ﹤0.01% 4332
2024
Q2 		$31.7K Hold
11,184
– – ﹤0.01% 4377
2024
Q1 		$49.8K Sell
11,184
-60
-0.5% -$317 ﹤0.01% 4322
2023
Q4 		$86K Hold
11,244
– – ﹤0.01% 4227
2023
Q3 		$81.4K Buy
11,244
+3,796
+51% +$31.4K ﹤0.01% 4311
2023
Q2 		$69.7K Hold
7,448
– – ﹤0.01% 4439
2023
Q1 		$123K Hold
7,448
– – ﹤0.01% 4261
2022
Q4 		$199K Sell
7,448
-16
-0.2% -$799 ﹤0.01% 4107
2022
Q3 		$394K Sell
7,464
-1,446
-16% -$111K ﹤0.01% 3852
2022
Q2 		$799K Sell
8,910
-3,170
-26% -$240K ﹤0.01% 3523
2022
Q1 		$1.04M Sell
12,080
-852
-7% -$75.2K ﹤0.01% 3599
2021
Q4 		$1.18M Sell
12,932
-1,211
-9% -$181K ﹤0.01% 3633
2021
Q3 		$2.86M Buy
14,143
+2,589
+22% +$779K ﹤0.01% 3205
2021
Q2 		$5.37M Buy
11,554
+7,208
+166% +$3M ﹤0.01% 2853
2021
Q1 		$891K Buy
+4,346
New +$759K ﹤0.01% 3604

Other funds holding GTBP

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
AAP
Arax Advisory Partners Denver, Colorado $3.54B AUM 19.14% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SWM
SeaCrest Wealth Management Purchase, New York $903M AUM 47.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
I
INVST Indianapolis, Indiana $886M AUM 21.79% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Geode Capital Management's GTBP Position: Q1 2026 in Review

Geode Capital Management increased its GT Biopharma (GTBP) stake by 1,429% in Q1 2026, buying an estimated $150K and bringing the position to 294,459 shares worth $120K. The position accounts for ﹤0.01% of the portfolio, ranked #4086.

Geode Capital Management first reported a position in GTBP in Q1 2021 and has held it in 21 quarters since. The position peaked at $5.37M in Q2 2021. 42 funds tracked by Wall St. Rank hold GTBP as of Q1 2026.

  • Geode Capital Management held 294,459 shares of GT Biopharma worth $120K as of Q1 2026.
  • Geode Capital Management bought 275,201 GT Biopharma shares in Q1 2026, an estimated $150K.
  • GT Biopharma made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #4086 holding.
  • Geode Capital Management first reported a position in GT Biopharma in Q1 2021 and has held it in 21 quarters since.
  • Geode Capital Management's GT Biopharma position peaked at $5.37M in Q2 2021.
  • 42 funds tracked by Wall St. Rank held GT Biopharma as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.